نتائج البحث - Azeez Farooki

  • يعرض 1 - 16 نتائج من 16
تنقيح النتائج
  1. 1
    Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies

    Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies حسب José O. Alemán, Azeez Farooki, Monica Girotra

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer

    Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer حسب Azeez Farooki, Vivien Leung, Hernán Tala, R. Michael Tuttle

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy

    Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy حسب Samantha Peiling Yang, Tae W. Kim, Patrick J. Boland, Azeez Farooki

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Bone Mineral Density: Clinical Relevance and Quantitative Assessment

    Bone Mineral Density: Clinical Relevance and Quantitative Assessment حسب Katherine Haseltine, Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian, Azeez Farooki

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Osteonecrosis of the Jaw Related to Bevacizumab

    Osteonecrosis of the Jaw Related to Bevacizumab حسب Cherry L. Estilo, Monica Fornier, Azeez Farooki, Diane L. Carlson, George C. Bohle, Joseph M. Huryn

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

    Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway حسب Naifa L. Busaidy, Azeez Farooki, Afshin Dowlati, John P. Perentesis, Janet Dancey, L. Austin Doyle, Joanna M. Brell, Lillian L. Siu

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Molecular profiling of oral microbiota in jawbone samples of bisphosphonate‐related osteonecrosis of the jaw

    Molecular profiling of oral microbiota in jawbone samples of bisphosphonate‐related osteonecrosis of the jaw حسب Xiaoyuan Wei, Smruti Pushalkar, Cherry L. Estilo, Cho Lee Wong, Azeez Farooki, Monica Fornier, George C. Bohle, Joseph M. Huryn, Yihong Li, Steven Doty, Deepak Saxena

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

    Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas حسب Bruce D. Cheson, Susan O’Brien, Michael S. Ewer, Marcus D. Goncalves, Azeez Farooki, Georg Lenz, Anthony F. Yu, Richard I. Fisher, Pier Luigi Zinzani, Martin Dreyling

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    NCCN Task Force Report: Bone Health in Cancer Care

    NCCN Task Force Report: Bone Health in Cancer Care حسب Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica Fornier, Robert F. Gagel, Rashmi Kumar, Charles L. Shapiro, Andrew Shields, Matthew Smith, Sandy Srinivas, Catherine Van Poznak

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management

    The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management حسب Monica Girotra, Aaron R. Hansen, Azeez Farooki, David J. Byun, Le Min, Ben Creelan, Margaret K. Callahan, Michael B. Atkins, Elad Sharon, Scott Antonia, Pamela West, Amy Gravell

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    NCCN Task Force Report: Bone Health in Cancer Care

    NCCN Task Force Report: Bone Health in Cancer Care حسب Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica Fornier, Robert F. Gagel, Rashmi Kumar, Georgia Litsas, Rana R. McKay, Donald A. Podoloff, Sandy Srinivas, Catherine Van Poznak

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Osteonecrosis of the Maxilla and Mandible in Patients with Advanced Cancer Treated with Bisphosphonate Therapy

    Osteonecrosis of the Maxilla and Mandible in Patients with Advanced Cancer Treated with Bisphosphonate Therapy حسب Cherry L. Estilo, Catherine Van Poznak, Tijaana Wiliams, George C. Bohle, Phyu T. Lwin, Qin Zhou, Elyn Riedel, Diane L. Carlson, Heiko Schöder, Azeez Farooki, Monica Fornier, Jerry Halpern, Steven Tunick, Joseph M. Huryn

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

    A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer حسب Kathleen N. Moore, Camille C. Gunderson, Paul Sabbatini, D. Scott McMeekin, Gina Mantia-Smaldone, Robert A. Burger, Mark A. Morgan, Ann M. Kapoun, Rainer K. Brachmann, Robert Stagg, Azeez Farooki, Roisin E. O’Cearbhaill

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

    Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer حسب Jennifer R. Diamond, Carlos Becerra, Donald Richards, Alain C. Mita, Cynthia R. Osborne, Joyce O’Shaughnessy, Chun Zhang, Randall Henner, Ann M. Kapoun, Lu Xu, Bob Stagg, Shailaja Uttamsingh, Rainer K. Brachmann, Azeez Farooki, Monica Mita

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update Executive Summary

    American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 202... حسب Pauline M. Camacho, Steven M. Petak, Neil Binkley, Dima L. Diab, Leslie S. Eldeiry, Azeez Farooki, Steven T. Harris, Daniel L. Hurley, Jenny Kelly, E. Michael Lewiecki, Rachel Pessah‐Pollack, Michael R. McClung, Sunil J. Wimalawansa, Nelson B. Watts

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

    Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique حسب Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura M. Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobágyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee S. Schwartzberg, Michael S. Broder

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: